Structure- and physics-based molecular modeling, docking and cheminformatics are used where appropriate to help prioritize compounds, test hypotheses and focus experimental work where it matters most.
Better prioritization. Fewer low-value compounds. Clearer experimental hypotheses.
The toolbox is used when a chemistry or structural decision would benefit from systematic computational analysis before more compounds are made or more experiments are commissioned.
Prioritize plausible designs when synthesis capacity or assay bandwidth is limited.
Compare proposed binding modes, interactions and alternative structural interpretations.
Use structural and series-level analysis to generate testable explanations for unexpected activity patterns.
Compare relevant molecular states and alternative poses when they could materially affect the design decision.
Reduce larger enumerated sets to a chemically and experimentally practical shortlist.
Stress-test the current design rationale against alternative poses, analogues and structural comparisons.
Protein-structure selection, preparation, alignment, binding-site comparison and interaction analysis to establish a useful structural basis for the question.
Pose generation, scoring, comparison and interaction-based review, with emphasis on comparative interpretation rather than a single docking score.
Integrating structural compatibility, medicinal-chemistry context, molecular properties and project-specific criteria to rank ideas for follow-up.
Similarity, substructure, matched-pair, scaffold and analogue analysis using reproducible RDKit / Python workflows.
Filtering and prioritization of virtual or enumerated compound sets, including pharmacophore and structure-guided design support where appropriate.
Purpose-built analyses for a defined program question, rather than forcing every project through the same fixed software pipeline.
Focus the next design cycle when many analogues are plausible but synthesis or assay capacity is limited.
Compare structural explanations and generate testable hypotheses when activity changes are clear but the reason is not.
Assess programs where binary binding, ternary-complex geometry and interface effects may all influence compound behavior.
Review CRO proposals, design logic and larger virtual libraries before synthesis, procurement or other resources are committed.
Docking scores, structural models and computational rankings are treated as comparative evidence rather than direct predictions of potency, degradation or clinical performance. Conclusions are reported with uncertainty and interpreted alongside experimental data, medicinal chemistry and synthetic feasibility.
Share the question and whatever data or structures you already have. I can then define whether computational analysis is likely to change the decision and what a useful, bounded piece of work would look like.